3 results
Approved WMOCompleted
Our study tries to identify the ideal sclerosant dosage for the ClariVein® system in order to occlude the GSV permanently. By choosing the lowest dose with the same anatomical success rate, we achieve a safe treatment which also gives us the…
Approved WMOCompleted
Objective: To evaluate the anatomical success of MOCA versus RFA in treatment of symptomatic insufficient SSV.
Approved WMOCompleted
The purpose of the study is to validate the measurements of an activity and heart rate band. The primary objective of this study is to determine the measurement accuracy of the activity and heart rate band with regards to the measurement of energy…